The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Preferential response of cancer cells to zebularine
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143
The fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Self-citationCancer-epigenetics comes of age
Jones, P. A., & Laird, P. W. (1999) · Nature Genetics · doi:10.1038/5947 · Cited by 2,344
Self-citationCellular differentiation, cytidine analogs and DNA methylation
Jones, P. A., & Taylor, S. M. (1980) · Cell · doi:10.1016/0092-8674(80)90237-8 · Cited by 1,831
Self-citationThe p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
Waga, S., Hannon, G. J., Beach, D., & Stillman, B. (1994) · Nature · doi:10.1038/369574a0 · Cited by 1,655
DNA hypermethylation in tumorigenesis: epigenetics joins genetics
Baylin, S. B., & Herman, J. G. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(99)01971-x · Cited by 1,628
Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer
Baylin, S. B. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.687 · Cited by 929
Robertson, K. D., Uzvolgyi, E., Liang, G., Talmadge, C., Sumegi, J., Gonzales, F. A., & Jones, P. A. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.11.2291 · Cited by 853
Self-citationGonzalez‐Zulueta, M., Bender, C. M., Yang, A. S., Nguyen, T. T., Beart, R. W., Tornout, J. M. V., & Jones, P. A. (1995) · PubMed · Cited by 772
Self-citationThe activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.
De Smet, C., De Backer, O., Faraoni, I., Lurquin, C., Brasseur, F., & Boon, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7149 · Cited by 542
Inhibition of DNA Methylation and Reactivation of Silenced Genes by Zebularine
Cheng, J. C., Matsen, C. B., Gonzales, F. A., Ye, W., Greer, S., Marquez, V. E., Jones, P. A., & Selker, E. U. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.5.399 · Cited by 535
Self-citationCovalent bond formation between a DNA-cytosine methyltransferase and DNA containing 5-azacytosine.
Santi, D. V., Norment, A., & Garrett, C. E. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.22.6993 · Cited by 518
AdoMet-dependent methylation, DNA methyltransferases and base flipping
Cheng, X. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.18.3784 · Cited by 485
On the mechanism of inhibition of DNA-cytosine methyltransferases by cytosine analogs
Santi, D. V., Garrett, C. E., & Barr, P. J. (1983) · Cell · doi:10.1016/0092-8674(83)90327-6 · Cited by 401
Zhou, L., Cheng, X., Connolly, B. A., Dickman, M. J., Hurd, P. J., & Hornby, D. P. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00676-9 · Cited by 362
Weber, J. S., Salgaller, M. L., Samid, D., Johnson, B., Herlyn, M., Lassam, N. J., Treisman, J. S., & Rosenberg, S. A. (1994) · PubMed · Cited by 294
5-Azacytidine, a new, highly effective cancerostatic
Šorm, F., Pískala, A., Čihák, A., & Veselý, J. (1964) · Experientia · doi:10.1007/bf02135399 · Cited by 286
Cytotoxicity and mode of action of 5-azacytidine on L1210 leukemia.
Li, L. H., Olin, E. J., Buskirk, H. H., & REINEKE, L. M. (1970) · PubMed · Cited by 263
Tam, S. W., Shay, J. W., & Pagano, M. (1994) · PubMed · Cited by 241
Continuous Zebularine Treatment Effectively Sustains Demethylation in Human Bladder Cancer Cells
Cheng, J. C., Weisenberger, D. J., Gonzales, F. A., Liang, G., Xu, G.-L., Hu, Y.-G., Marquez, V. E., & Jones, P. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.1270-1278.2004 · Cited by 222
Self-citationLiang, G., Gonzales, F. A., Jones, P. A., Orntoft, T. F., & Thykjær, T. (2002) · PubMed · Cited by 205
Self-citationRobertson, K. D. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.10.2108 · Cited by 199
Kondo, T. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.4.597 · Cited by 174
Lübbert, M. (2000) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-59696-4_9 · Cited by 169
Liu, K., Wang, Y. F., Cantemir, C., & Muller, M. T. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.8.2709-2719.2003 · Cited by 160
Karpf, A. R., Lasek, A. W., Ririe, T. O., Hanks, A. N., Grossman, D., & Jones, D. A. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.1.18 · Cited by 150
Bouchard, J., & Momparler, R. L. (1983) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14371-x · Cited by 102
Cell division is required for de novo methylation of CpG islands in bladder cancer cells.
Velicescu, M., Weisenberger, D. J., Gonzales, F. A., Tsai, Y., Nguyen, C. T., & Jones, P. A. (2002) · PubMed · Cited by 97
Self-citationLalibert�, J., Márquez, V. E., & Momparler, R. L. (1992) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00686478 · Cited by 97
The absence of p53 is critical for the induction of apoptosis by 5-aza-2′-deoxycytidine
Nieto, M. D., Samper, E., Fraga, M. F., de Buitrago, G. G., Esteller, M., & Serrano, M. (2004) · Oncogene · doi:10.1038/sj.onc.1207175 · Cited by 92
Soejima, K., Fang, W., & Rollins, B. J. (2003) · Oncogene · doi:10.1038/sj.onc.1206510 · Cited by 91
Synthesis of pyrimidin-2-one nucleosides as acid-stable inhibitors of cytidine deaminase
Kim, C. H., Márquez, V. E., Mao, D. T., Haines, D. R., & McCormack, J. J. (1986) · Journal of Medicinal Chemistry · doi:10.1021/jm00158a009 · Cited by 82
Gong, J., Ammanamanchi, S., Ko, T. C., & Brattain, M. G. (2003) · PubMed · Cited by 73
Mechanism-based inhibition of C5-cytosine DNA methyltransferases by 2-H pyrimidinone
Hurd, P. J., Whitmarsh, A. J., Baldwin, G. S., Kelly, S. M., Waltho, J. P., Price, N. C., Connolly, B. A., & HORNBY, D. P. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2491 · Cited by 72
Ilyin, G. P., Glaise, D., Gilot, D., Baffet, G., & Guguen‐Guillouzo, C. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00309.2002 · Cited by 65
The mechanism of inhibition of protein synthesis by 5-azacytidine in HeLa cells
Reichman, M. E., & Penman, S. (1973) · Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis · doi:10.1016/0005-2787(73)90145-7 · Cited by 52
5-Azacytidine, DNA Methylation, and Differentiation
Taylor, S. M., Constantinides, P. A., & Jones, P. A. (1984) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-69370-0_8 · Cited by 46
Self-citation
Cited by
Jones, P. A., & Baylin, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.01.029 · Cited by 4,515
Self-citationSharma, S., Kelly, T. K., & Jones, P. A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp220 · Cited by 2,637
Self-citationBiomarkers in Cancer Staging, Prognosis and Treatment Selection
Ludwig, J. A., & Weinstein, J. N. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1739 · Cited by 1,666
Kulis, M., & Esteller, M. (2010) · Advances in Genetics · doi:10.1016/b978-0-12-380866-0.60002-2 · Cited by 1,566
Epigenetic therapy of cancer: past, present and future
Yoo, C. B., & Jones, P. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1930 · Cited by 1,289
Self-citation
Metadata
- Authors
- Cheng, J. C., Yoo, C. B., Weisenberger, D. J., Chuang, J., Wozniak, C., Liang, G., Marquez, V. E., Greer, S., Orntoft, T. F., Thykjaer, T., & Jones, P. A.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2004-08
- Volume
- 6
- Issue
- 2
- Pages
- 151-158
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2061578142
- Cited by
- 319
- References
- 37
- FWCI
- 7.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.